KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL Test
Test Name: KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL
Test Components:
- pH
- Creatinine
- Calcium
- Magnesium
- Citrate
- Oxalate
- Osmolality
- Sodium
- Uric Acid
- Phosphorus
Price: 1100.0 AED
Sample Condition:
Day 1: 50 mL (30 mL min.) aliquot of 24-hour urine. Do not use preservatives. Mention total volume on Test Request Form & label container as Non-acidified urine.
Day 2: 50 mL (30 mL min.) aliquot of 24-hour urine. Collect urine with 25 mL 50% concentrated HCl to maintain pH below 3. Mention total volume on Test Request Form & label container as Acidified urine. Ship both specimens frozen. DO NOT THAW. Record patient weight on Test Request Form.
Report Delivery: Sample Wed / Sat by 9 am; Report Same day
Method: Spectrophotometry, Enzymatic, Indirect ISE
Test type: Disorders of Kidney, Disorders of Urinary tract
Doctor: Nephrologist, Urologist
Test Department:
Pre Test Information: Patient body weight required.
Test Details:
The Kidney Stone Formation Therapeutic Monitoring Panel test is a diagnostic tool used to assess and monitor the effectiveness of treatment for kidney stones. This panel includes several tests that provide information about the composition and risk factors associated with kidney stone formation. The tests included in this panel may vary, but commonly include:
- Complete Blood Count (CBC): This test measures the levels of red and white blood cells, as well as platelets. Abnormalities in these levels may indicate an underlying condition contributing to kidney stone formation.
- Urinalysis: This test examines the physical and chemical properties of urine, including the presence of blood, crystals, or infection. It helps identify the type of kidney stone and provides information about the pH and specific gravity of the urine.
- Urine Culture: This test is performed to detect the presence of bacteria in the urine, which can indicate a urinary tract infection. Infections can increase the risk of kidney stone formation.
- Serum Calcium: This test measures the level of calcium in the blood. High levels of calcium may indicate hypercalcemia, which can contribute to the formation of calcium-based kidney stones.
- Serum Uric Acid: This test measures the level of uric acid in the blood. Elevated levels of uric acid can lead to the formation of uric acid stones.
- Serum Creatinine: This test measures the level of creatinine in the blood, which is an indicator of kidney function. Kidney stones can cause kidney damage, so monitoring creatinine levels is important in assessing kidney health.
- 24-Hour Urine Collection: This test involves collecting all urine produced over a 24-hour period to measure the levels of various substances, such as calcium, oxalate, citrate, and uric acid. These measurements help identify specific factors contributing to kidney stone formation and guide treatment strategies.
By analyzing the results of these tests, healthcare providers can determine the underlying cause of kidney stone formation and adjust treatment plans accordingly. Regular monitoring of these parameters can help prevent the recurrence of kidney stones and monitor the effectiveness of ongoing treatment.
Test Name | KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL Test |
---|---|
Components | *pH*Creatinine*Calcium*Magnesium *Citrate*Oxalate*Osmolality*Sodium*Uric Acid*Phosphorus |
Price | 1100.0 AED |
Sample Condition | Day 1: 50 mL (30 mL min.) aliquot of 24-hour urine. Do not use preservatives. Mention total volume on Test Request Form & label container asNon-acidified urine.\nDay 2: 50 mL (30 mL min.) aliquot of 24 hour urine. Collect urine with 25 mL 50% concentrated HCl to maintain pH below 3. Mention total volume on Test Request Form & label container as Acidified urine. Ship both specimens frozen. DO NOT THAW. Record patient weight on Test Request Form. |
Report Delivery | Sample Wed / Sat by9 am; Report Same day |
Method | Spectrophotometry, Enzymatic, Indirect ISE |
Test type | Disorders of Kidney, Disorders of Urinary tract |
Doctor | Nephrologist, Urologist |
Test Department: | |
Pre Test Information | Patient body weight required. |
Test Details |
The Kidney Stone Formation Therapeutic Monitoring Panel test is a diagnostic tool used to assess and monitor the effectiveness of treatment for kidney stones. This panel includes several tests that provide information about the composition and risk factors associated with kidney stone formation. The tests included in this panel may vary, but commonly include: 1. Complete Blood Count (CBC): This test measures the levels of red and white blood cells, as well as platelets. Abnormalities in these levels may indicate an underlying condition contributing to kidney stone formation. 2. Urinalysis: This test examines the physical and chemical properties of urine, including the presence of blood, crystals, or infection. It helps identify the type of kidney stone and provides information about the pH and specific gravity of the urine. 3. Urine Culture: This test is performed to detect the presence of bacteria in the urine, which can indicate a urinary tract infection. Infections can increase the risk of kidney stone formation. 4. Serum Calcium: This test measures the level of calcium in the blood. High levels of calcium may indicate hypercalcemia, which can contribute to the formation of calcium-based kidney stones. 5. Serum Uric Acid: This test measures the level of uric acid in the blood. Elevated levels of uric acid can lead to the formation of uric acid stones. 6. Serum Creatinine: This test measures the level of creatinine in the blood, which is an indicator of kidney function. Kidney stones can cause kidney damage, so monitoring creatinine levels is important in assessing kidney health. 7. 24-Hour Urine Collection: This test involves collecting all urine produced over a 24-hour period to measure the levels of various substances, such as calcium, oxalate, citrate, and uric acid. These measurements help identify specific factors contributing to kidney stone formation and guide treatment strategies. By analyzing the results of these tests, healthcare providers can determine the underlying cause of kidney stone formation and adjust treatment plans accordingly. Regular monitoring of these parameters can help prevent the recurrence of kidney stones and monitor the effectiveness of ongoing treatment. |